Shares of Zomato fell by 4.8% following Jefferies' downgrade of the stock from 'buy' to 'hold' and a 18% cut in the target ...

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

Zomato receives positive outlook from analysts, maintaining "Overweight" rating with target price of 355, despite recent ...

Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...

The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...

Investing.com-- Jefferies downgraded Indian food delivery firm Zomato Ltd (NS: ZOMT) on Monday, stating that the stock was ...

Jefferies Financial Group Inc. JEF is slated to report fourth-quarter and full-year fiscal 2024 (ended Nov. 30) results ...

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

New Delhi, Jan. 7 -- zomato | zomato share | zomato share price | zomato share news | zomato price target | zomato stock ...

Zomato's stock price was down 4.19% to Rs 253.75 on the Bombay Stock Exchange (BSE). Earlier, the shares of Zomato hit an ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Procore Technologies was upgraded to Buy from Hold by Jefferies as the financial firm listed the software company among its top picks for 2025. Read more here.